Pregnancy After STDs: Fertility Risks and Prevention
Impact of Sexually Transmitted Infections on Fertility and Pregnancy
Sexually transmitted infections (STIs) can affect fertility and pregnancy outcomes, but the impact varies by pathogen, timeliness of treatment, and individual factors. Early detection and treatment are key to preserving reproductive health.
STIs That Can Cause Infertility
| Infection | Mechanism | Key Points |
|---|---|---|
| Chlamydia trachomatis | Ascending infection → cervicitis → endometritis → salpingitis → tubal scarring/occlusion | Often asymptomatic; #1 cause of tubal factor infertility. PID risk ~10–40% if untreated. |
| Neisseria gonorrhoeae | Similar ascending spread; more acute inflammation | Higher per-act transmission; also causes PID, tubal damage. Often co-infects with chlamydia. |
| Mycoplasma genitalium | Emerging cause of PID, cervicitis | Increasing antibiotic resistance; associated with tubal factor infertility. |
STIs Less Directly Linked to Infertility but Relevant to Pregnancy
| Infection | Pregnancy/Perinatal Impact |
|---|---|
| HSV (Herpes Simplex Virus) | Neonatal herpes if active lesions at delivery → C-section indicated. No effect on fertility. |
| HPV (Human Papillomavirus) | Cervical dysplasia/cancer from high-risk types; treatment (LEEP, cone) may weaken cervix → preterm birth risk. No direct infertility. |
| Syphilis (Treponema pallidum) | Congenital syphilis (stillbirth, neonatal death, deformities) if untreated. Screen all pregnant women. Penicillin curative. |
| HIV | Perinatal transmission <1% with ART + viral suppression. Fertility reduced if advanced immunosuppression. |
| Trichomonas vaginalis | Preterm birth, low birth weight, PID risk. Treat in pregnancy (metronidazole). |
| HBV/HCV | Vertical transmission (HBV: ~90% without immunoprophylaxis; HCV: ~5–6%). No direct infertility. |
Prevention and Early Intervention
- Routine screening: CDC recommends annual chlamydia/gonorrhea screening for all sexually active women <25, and older women with risk factors. Screen at first prenatal visit.
- Partner treatment: Expedited partner therapy (EPT) for chlamydia/gonorrhea reduces reinfection.
- Vaccination: HPV vaccine (9-valent) prevents oncogenic and genital wart types. HBV vaccine prevents hepatitis B.
- Condom use: Consistent, correct use reduces transmission of all STIs.
- Prompt treatment: Single-dose azithromycin (chlamydia) or ceftriaxone + azithromycin (gonorrhea) cures most cases, preventing sequelae.
Assisted Reproduction Considerations
For couples with tubal factor infertility from prior STI, IVF bypasses tubes. Pre-IVF screening for active infection is mandatory. Hydrosalpinges should be removed or occluded to improve implantation rates.
Most STIs are treatable or manageable. With proactive sexual health care, the vast majority of people with STI history achieve healthy pregnancies.
Pregnancy & Health - Related Articles
- Down Syndrome Screening During Pregnancy: Age and Risk Factors
- Grapefruit Diet & Pregnancy: Risks & Safe Nutrition
- Pregnancy Detection Timeline: Earliest Positive Test After Intercourse
- Postpartum Hip Recovery: Timeline, Exercises, and Pain Management
- Pregnancy Quiz: Understanding What AI Can & Cannot Do
- When to Have a Baby Shower: Optimal Timing for the Expectant Mother
- Drotin (Spironolactone) Contraindicated in Pregnancy: Fetal Risks in Second/Third Trimester
